Mark Guinan's Net Worth
$27.1 Million
Who is Mark Guinan?
Mark Guinan has an estimated net worth of $27.1 Million. This is based on reported shares across multiple companies, which include UpHealth, Inc., QUEST DIAGNOSTICS INC, Myovant Sciences Ltd., and Hill-Rom Holdings, Inc..
SEC CIK
Mark Guinan's CIK is 0001505998
Past Insider Trading and Trends
2020 was Mark Guinan's most active year for acquiring shares with 6 total transactions. Mark Guinan's most active month to acquire stocks was the month of January. 2020 was Mark Guinan's most active year for disposing of shares, totalling 11 transactions. Mark Guinan's most active month to dispose stocks was the month of January. 2020 saw Mark Guinan paying a total of $11,423,245.66 for 229,920 shares, this is the most they've acquired in one year. In 2019 Mark Guinan cashed out on 154,124 shares for a total of $11,816,956.84, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
UpHealth, Inc. (UPH) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +165.00% | 100K |
—
|
—
| 160.61K |
Jan 31
| |||
Form 4
|
∞
| 60.61K |
—
|
—
| 60.61K |
Dec 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
QUEST DIAGNOSTICS INC (DGX) Snapshot price: $152.543
Executive Vice President & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.62% | 10.3K |
$130.09 | $1,340,577.45 | 98.98K |
Mar 7
| |||
Form 4
| +2.60% | 2.25K |
—
|
—
| 88.68K |
Feb 24
| |||
Form 4
| -2.67% | -2.37K |
$130.13 | -$308,020.19 | 86.42K |
Feb 23
| |||
Form 4
| +14.02% | 10.92K |
$115.42 | $1,260,270.98 | 88.79K |
Mar 9
| |||
Form 4
| -1.73% | -1.37K |
$121.17 | -$166,118.29 | 77.87K |
Feb 23 - Feb 24
| |||
Form 4
| +7.70% | 5.67K |
—
|
—
| 79.24K |
Feb 17
| |||
Form 4
|
—
|
0
|
$93.44 | -$4,403,081.65 | 73.58K |
Scheduled
|
Dec 24
| ||
Form 4
|
—
|
0
|
$94.20 | -$3,343,927.72 | 73.58K |
Scheduled
|
Jun 8
| ||
Form 4
| +5.48% | 3.82K |
$106.46 | $406,996.58 | 73.58K |
Mar 10
| |||
Form 4
| -1.68% | -1.20K |
$112.90 | -$134,915.50 | 69.76K |
Feb 26
| |||
Form 4
| -1.69% | -1.22K |
$112.71 | -$137,284.11 | 70.95K |
Feb 24 - Feb 25
| |||
Form 4
| +9.32% | 6.15K |
—
|
—
| 72.17K |
Feb 18
| |||
Form 4
|
—
|
0
|
$76.09 | -$3,492,194.17 | 66.02K |
Jun 13
| |||
Form 4
| +8.99% | 5.45K |
$86.86 | $473,213.28 | 66.02K |
Mar 1
| |||
Form 4
| -2.50% | -1.56K |
$87.84 | -$136,679.04 | 60.57K |
Feb 26
| |||
Form 4
| -1.05% | -660.00 |
$88.24 | -$58,238.40 | 62.13K |
Feb 25
| |||
Form 4
| -0.96% | -610.00 |
$88.39 | -$53,917.90 | 62.78K |
Feb 22
| |||
Form 4
| +8.93% | 5.2K |
—
|
—
| 63.4K |
Feb 18
| |||
Form 4
|
—
|
0
|
$82.04 | -$2,913,308.40 | 58.2K |
Scheduled
|
May 25
| ||
Form 4
| +12.94% | 6.67K |
$101.00 | $673,266.00 | 58.2K |
Mar 2
| |||
Form 4/A
| -1.49% | -779.00 |
$101.43 | -$79,013.97 | 51.53K |
Feb 27
| |||
Form 4/A
| -3.76% | -2.05K |
$101.79 | -$208,271.70 | 52.31K |
Feb 23 - Feb 26
| |||
Form 4
| -1.11% | -585.00 |
$101.43 | -$59,336.55 | 52.09K |
Feb 27
| |||
Form 4
| -3.10% | -1.68K |
$101.87 | -$171,554.04 | 52.67K |
Feb 23 - Feb 26
| |||
Form 4
| +8.90% | 4.44K |
—
|
—
| 54.36K |
Feb 19
| |||
Form 4
| +16.01% | 6.89K |
$98.12 | $675,948.68 | 49.92K |
Mar 2
| |||
Form 4
| -1.43% | -625.00 |
$96.42 | -$60,262.50 | 43.03K |
Feb 28
| |||
Form 4
| -1.32% | -585.00 |
$95.68 | -$55,972.80 | 43.65K |
Feb 24
| |||
Form 4
| +12.18% | 4.8K |
—
|
—
| 44.24K |
Feb 21
| |||
Form 4
| -3.55% | -1.45K |
$93.85 | -$136,176.35 | 39.44K |
Feb 13
| |||
Form 4
| -17.11% | -8.44K |
$84.57 | -$713,770.80 | 40.89K |
Aug 22
| |||
Form 4
| +3.41% | 1.63K |
$67.01 | $108,891.25 | 49.33K |
Mar 1
| |||
Form 4
| +13.75% | 5.76K |
$66.44 | -$36,542.00 | 47.7K |
Feb 25
| |||
Form 4
| -1.73% | -739.00 |
$61.95 | -$45,781.05 | 41.94K |
Feb 16
| |||
Form 4
| -7.50% | -3.46K |
$73.28 | -$253,695.36 | 42.68K |
Aug 21
| |||
Form 4
| +14.67% | 5.9K |
—
|
—
| 46.14K |
Feb 23
| |||
Form 4
| -1.23% | -1.00K |
$71.58 | -$71,648.16 | 80.7K |
Feb 17
| |||
Form 4
| -6.86% | -3.03K |
$61.99 | -$188,015.67 | 41.19K |
Aug 20
| |||
Form 4
| +9.94% | 4K |
$55.51 | $222,023.20 | 44.22K |
May 5
| |||
Form 4
| +23.55% | 7.67K |
—
|
—
| 40.22K |
Feb 13
| |||
Form 4
|
∞
| 32.55K |
—
|
—
| 32.55K |
Aug 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Myovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.67K |
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
∞
| 9.86K |
—
|
—
| 9.86K |
Oct 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Hill-Rom Holdings, Inc. No price found
Sr. VP & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +56.91% | 6.9K |
$28.98 | -$93,402.54 | 19.04K |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 4
| +142.64% | 7.13K |
$31.85 | -$100,072.70 | 12.13K |
Dec 14
| |||
Form 4
|
∞
| 5K |
$41.85 | $209,250.00 | 5K |
Dec 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||